Publications by authors named "Shogo Marui"

Claim this Profile
S
Structure-Based Design and Synthesis of 3-Amino-1,5-dihydro-4H-pyrazolopyridin-4-one Derivatives as Tyrosine Kinase 2 Inhibitors.
Takatoshi Yogo, Hiroyuki Nagamiya, Masaki Seto, Satoshi Sasaki, Huang Shih-Chung, Shogo Marui

J Med Chem· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a potent and orally available acyl-CoA: cholesterol acyltransferase inhibitor as an anti-atherosclerotic agent: (4-phenylcoumarin)acetanilide derivatives.
Masaki Ogino, Seiji Fukui, Yoshihisa Nakada, Ryosuke Tokunoh, Shigekazu Itokawa, Shogo Marui

Chem Pharm Bull (Tokyo)· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a novel acyl-CoA: cholesterol acyltransferase inhibitor: the synthesis, biological evaluation, and reduced adrenal toxicity of (4-phenylcoumarin)acetanilide derivatives with a carboxylic acid moiety.
Masaki Ogino, Yoshihisa Nakada, Nobuyuki Negoro, Shigekazu Itokawa, Satoshi Nishimura, Shogo Marui

Chem Pharm Bull (Tokyo)· March 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of potent, selective, orally active benzoxazepine-based Orexin-2 receptor antagonists.
Tatsuhiko Fujimoto, Jun Kunitomo, Yoshihide Tomata, Keiji Nishiyama, Masato Nakashima, Shogo Marui

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of spiropiperidine-based potent and selective Orexin-2 receptor antagonists.
Tatsuhiko Fujimoto, Yoshihide Tomata, Jun Kunitomo, Mariko Hirozane, Shogo Marui

Bioorg Med Chem Lett· November 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis